|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1969-9-30
|
|
pubmed:abstractText |
By following careful procedures, mycobacterial ribosomal fractions and ribonucleic acid (RNA) prepared by ethyl alcohol precipitation were obtained which have immunogenic activities similar to the viable attenuated H37Ra cells of Mycobacterium tuberculosis from which they were obtained. This comparison was based on the amount of ribonucleic acid (RNA) present. These preparations consisted of approximately 63% RNA and 37% protein; no deoxyribonucleic acid or polysaccharide was detected by chemical tests. A high correlation was found between the immunogenic activity of a preparation and the per cent increase in hyperchromicity at 260 nm of a ribonuclease-hydrolyzed portion. Final concentrations of sodium dodecyl sulfate higher than 0.25% when used for the preparation of the ribosomal fractions and RNA resulted in significantly lower immune responses and greater variation between experiments. This was not related to the amount of protein present. The stability of the ribosomal and RNA preparations was tested under a variety of conditions. The need for a good protective adjuvant again was shown since mouse serum readily hydrolyzed the RNA. Equal immunity was obtained after immunization by the intraperitoneal and subcutaneous routes; however, no immune response was obtained when the intravenous route was used. Preliminary results with RNA prepared with phenol showed that it was more easily degraded during preparation. This resulted in a lower immune response than was obtained with the RNA prepared with ethyl alcohol.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-12980992,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13252018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13271291,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13321939,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13403157,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13449321,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13751111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13843704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13843706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13843707,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-13843708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-14151045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-14188712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-14219015,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-14293000,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-14907713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-4236903,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-4957609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-4957610,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-4963785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-4966539,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-5342714,
http://linkedlifedata.com/resource/pubmed/commentcorrection/4979447-5642572
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0021-9193
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
42-50
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:4979447-Animals,
pubmed-meshheading:4979447-BCG Vaccine,
pubmed-meshheading:4979447-Bacterial Proteins,
pubmed-meshheading:4979447-Detergents,
pubmed-meshheading:4979447-Freund's Adjuvant,
pubmed-meshheading:4979447-Injections, Intraperitoneal,
pubmed-meshheading:4979447-Injections, Subcutaneous,
pubmed-meshheading:4979447-Male,
pubmed-meshheading:4979447-Mice,
pubmed-meshheading:4979447-Mycobacterium tuberculosis,
pubmed-meshheading:4979447-RNA, Bacterial,
pubmed-meshheading:4979447-Ribosomes,
pubmed-meshheading:4979447-Tuberculosis
|
|
pubmed:year |
1969
|
|
pubmed:articleTitle |
Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.
|
|
pubmed:publicationType |
Journal Article
|
